The challenge of vaccine safety

Robert M. Jacobson, Kim S. Zabel, Gregory A. Poland

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Vaccines always will involve some risk, and risk always involves some public concern. Although the benefits of routine vaccination greatly outweigh any adverse effects, our consumer society seeks to eliminate all risk. The balance of risk and benefit appears to falter by the very success of preventing disease: in the immediate absence of the disease, the resolve to vaccinate waivers. We cannot expect the public to think in terms of the decision analyst and carefully weigh probability, risk, and benefit in a numerical fashion. In fact, the public's approach toward vaccination is varied and unscientific. Recognizing these challenges, we propose a program of continued vigilance by increasing our scientific base and methodology, improving vaccine safety communication through research and resources, maintaining a tolerance of conscientious objection as a safety valve for mandated routine vaccination in civilians, and calling for more research funding for the development of new vaccines.

Original languageEnglish (US)
Pages (from-to)215-220
Number of pages6
JournalSeminars in Pediatric Infectious Diseases
Volume13
Issue number3
DOIs
StatePublished - Jul 2002

Fingerprint

Vaccination
Vaccines
Safety
Research

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pediatrics, Perinatology, and Child Health

Cite this

Jacobson, R. M., Zabel, K. S., & Poland, G. A. (2002). The challenge of vaccine safety. Seminars in Pediatric Infectious Diseases, 13(3), 215-220. https://doi.org/10.1053/spid.2002.125865

The challenge of vaccine safety. / Jacobson, Robert M.; Zabel, Kim S.; Poland, Gregory A.

In: Seminars in Pediatric Infectious Diseases, Vol. 13, No. 3, 07.2002, p. 215-220.

Research output: Contribution to journalArticle

Jacobson, RM, Zabel, KS & Poland, GA 2002, 'The challenge of vaccine safety', Seminars in Pediatric Infectious Diseases, vol. 13, no. 3, pp. 215-220. https://doi.org/10.1053/spid.2002.125865
Jacobson, Robert M. ; Zabel, Kim S. ; Poland, Gregory A. / The challenge of vaccine safety. In: Seminars in Pediatric Infectious Diseases. 2002 ; Vol. 13, No. 3. pp. 215-220.
@article{736475468b4343b8b447aca935886a75,
title = "The challenge of vaccine safety",
abstract = "Vaccines always will involve some risk, and risk always involves some public concern. Although the benefits of routine vaccination greatly outweigh any adverse effects, our consumer society seeks to eliminate all risk. The balance of risk and benefit appears to falter by the very success of preventing disease: in the immediate absence of the disease, the resolve to vaccinate waivers. We cannot expect the public to think in terms of the decision analyst and carefully weigh probability, risk, and benefit in a numerical fashion. In fact, the public's approach toward vaccination is varied and unscientific. Recognizing these challenges, we propose a program of continued vigilance by increasing our scientific base and methodology, improving vaccine safety communication through research and resources, maintaining a tolerance of conscientious objection as a safety valve for mandated routine vaccination in civilians, and calling for more research funding for the development of new vaccines.",
author = "Jacobson, {Robert M.} and Zabel, {Kim S.} and Poland, {Gregory A.}",
year = "2002",
month = "7",
doi = "10.1053/spid.2002.125865",
language = "English (US)",
volume = "13",
pages = "215--220",
journal = "Seminars in Pediatric Infectious Diseases",
issn = "1045-1870",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - The challenge of vaccine safety

AU - Jacobson, Robert M.

AU - Zabel, Kim S.

AU - Poland, Gregory A.

PY - 2002/7

Y1 - 2002/7

N2 - Vaccines always will involve some risk, and risk always involves some public concern. Although the benefits of routine vaccination greatly outweigh any adverse effects, our consumer society seeks to eliminate all risk. The balance of risk and benefit appears to falter by the very success of preventing disease: in the immediate absence of the disease, the resolve to vaccinate waivers. We cannot expect the public to think in terms of the decision analyst and carefully weigh probability, risk, and benefit in a numerical fashion. In fact, the public's approach toward vaccination is varied and unscientific. Recognizing these challenges, we propose a program of continued vigilance by increasing our scientific base and methodology, improving vaccine safety communication through research and resources, maintaining a tolerance of conscientious objection as a safety valve for mandated routine vaccination in civilians, and calling for more research funding for the development of new vaccines.

AB - Vaccines always will involve some risk, and risk always involves some public concern. Although the benefits of routine vaccination greatly outweigh any adverse effects, our consumer society seeks to eliminate all risk. The balance of risk and benefit appears to falter by the very success of preventing disease: in the immediate absence of the disease, the resolve to vaccinate waivers. We cannot expect the public to think in terms of the decision analyst and carefully weigh probability, risk, and benefit in a numerical fashion. In fact, the public's approach toward vaccination is varied and unscientific. Recognizing these challenges, we propose a program of continued vigilance by increasing our scientific base and methodology, improving vaccine safety communication through research and resources, maintaining a tolerance of conscientious objection as a safety valve for mandated routine vaccination in civilians, and calling for more research funding for the development of new vaccines.

UR - http://www.scopus.com/inward/record.url?scp=0036628945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036628945&partnerID=8YFLogxK

U2 - 10.1053/spid.2002.125865

DO - 10.1053/spid.2002.125865

M3 - Article

C2 - 12199618

AN - SCOPUS:0036628945

VL - 13

SP - 215

EP - 220

JO - Seminars in Pediatric Infectious Diseases

JF - Seminars in Pediatric Infectious Diseases

SN - 1045-1870

IS - 3

ER -